Pharma companies have used healthcare professional personas for years, but many are still built on limited interviews, workshops and internal assumptions. That makes them useful for alignment, but less useful for execution. If personas do not reflect how clinicians actually think, speak and make decisions in practice, they can weaken messaging, waste spend and reduce the impact of evidence.
Traditional approaches tend to capture what healthcare professionals say in a formal research setting. They are less effective at showing what drives behaviour in real clinical environments, where time pressure, patient complexity, reimbursement issues and changing guidance all shape decisions. As a result, a persona can look credible on paper while failing to explain what really affects uptake.
If a company is working from an outdated or simplified view of its audience, it may focus on the wrong barriers, use evidence in the wrong way or miss the language that actually builds confidence.
The value here is not simply richer insight. It is better accuracy. Real-world language can reveal how clinicians frame problems, what concerns they return to, what evidence they trust and what practical issues affect action. That produces a more grounded view of the audience and gives teams a stronger basis for message development.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.
